Asthma and carotid artery plaques - 04/05/23
Doi : 10.1016/j.jaci.2023.02.022
Juan Carlos Cardet, MD, MPH a, ⁎ 
, Natalia Weare-Regales, MD b, c, Richard F. Lockey, MD, MS a, d, ⁎
, Natalia Weare-Regales, MD b, c, Richard F. Lockey, MD, MS a, d, ⁎ a Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, Fla
b Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, Fla
c Division of Endocrinology, Department of Internal Medicine, James A. Haley Veterans Administration, Tampa, Fla
d Division of Allergy and Immunology, Department of Internal Medicine, James A. Haley Veterans Administration, Tampa, Fla
∗Corresponding author: Juan Carlos Cardet, MD, MPH, University of South Florida Asthma, Allergy, and Immunology Clinical Research Unit, 13801 Bruce B. Downs Blvd, Suite 505, Tampa, FL 33613.University of South Florida AsthmaAllergyand Immunology Clinical Research Unit13801 Bruce BDowns BlvdSuite 505TampaFL33613∗∗Richard F. Lockey, MD, MS, University of South Florida Asthma, Allergy, and Immunology Clinical Research Unit, 13801 Bruce B. Downs Blvd, Suite 505, Tampa, FL 33613.University of South Florida AsthmaAllergyand Immunology Clinical Research Unit13801 Bruce B. Downs BlvdSuite 505TampaFL33613
Key words : MESA, phenotype, inflammation, type 2 inflammation, cardiovascular disease, epidemiology, asthma subsets, inhaled corticosteroids, IL-6, C-reactive protein
Il testo completo di questo articolo è disponibile in PDF.
| Supported by the National Institute of Allergy and Infectious Diseases (grant K23AI125785) and by the American Lung Association)/American Academy of Allergy, Asthma & Immunology (Allergic Respiratory Diseases Research Award AI-835475 [to J.C.C.]). |
|
| Disclosure of potential conflict of interest: J. C. Cardet reports receiving honoraria from AstraZeneca, GSK, Genentech, and Sanofi for work on advisory boards and educational lectures on asthma. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2023
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 151 - N° 5
P. 1257-1258 - Maggio 2023 Ritorno al numero
Articolo precedente
- Gene therapy for SCID, now up to 3!
- Alain Fischer, Bénédicte Neven
- Phospholipid remodeling and its derivatives are associated with COVID-19 severity
- Juntong Wei, Xiaoyu Liu, Weimin Xiao, Jiahua Lu, Li Guan, Zhangfu Fang, Jiaping Chen, Baoqing Sun, Zongwei Cai, Xizhuo Sun, Hua-Ling Chen, Nanshan Zhong, Zhigang Liu, Jun Yang, Xiaojun Xiao, Shau-Ku Huang
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?